Sermorelin vs Tesamorelin: GHRH Analog Research Comparison
A research-based comparison of sermorelin vs tesamorelin. Tesamorelin’s half-life is ~63 minutes, far longer than sermorelin’s ~12 minutes.
A research-based comparison of sermorelin vs tesamorelin. Tesamorelin’s half-life is ~63 minutes, far longer than sermorelin’s ~12 minutes.
Retatrutide is a triple agonist (GLP-1, GIP, GCGR). It differs from tirzepatide by adding glucagon receptor binding. Tirzepatide is a dual agonist (GLP-1, GIP).
A GLP-1 analog comparison covers semaglutide, liraglutide, and dulaglutide: structure, half-life, and receptor binding research in metabolic animal models.
Collagen peptide synthesis research maps how peptides signal fibroblasts. Studies on GHK-Cu show effects on COL1A1 gene expression in lab models.
GIP receptor peptide research maps how this class B GPCR triggers glucose-dependent insulin signaling. Studies examine dual agonists in lab models.
AMPK pathway peptide research maps how cells sense low energy and shift metabolism. Studies show AICAR and related compounds trigger AMPK in lab models.
Blood-brain barrier peptide research maps how peptides enter the CNS. Studies on Semax and Selank show these cross via active transport in lab models.
IGF-1 pathway research maps PI3K, Akt, and mTOR signaling. Studies show this cascade regulates cell growth, protein production, and survival in lab models.
An igf-1 lr3 vs mgf research comparison examining structure, half-life, receptor binding, and research applications of these two IGF-1 gene variants.
A research overview of peptide impurities: the types of contaminants in peptide batches and how HPLC and mass spec testing identifies each one.